Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 20, 2012 08:00 ET | Source: IRIS International, Inc.

IRIS International to Present NADiA ProsVue at Two Important Meetings in Washington DC Addressing the Role of Advanced Diagnostics in Cancer

CHATSWORTH, Calif., Sept. 20, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high...
September 17, 2012 08:22 ET | Source: IRIS International, Inc.

IRIS International Announces Agreement to be Acquired by Danaher Corporation for $19.50 per Share

CHATSWORTH, Calif., Sept. 17, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high...
July 31, 2012 16:05 ET | Source: IRIS International, Inc.

IRIS International Announces Second Quarter 2012 Revenue and Financial Results

Record revenue of $30.9 million in Q2 2012; 2% growth over Q2 2011 Gross margin of 54% in Q2 2012 GAAP EPS of $0.07 in Q2 2012 Reaffirming 2012 guidance of revenues in a range from...
July 19, 2012 16:05 ET | Source: IRIS International, Inc.

IRIS to Release Second Quarter Financial Results and Host Conference Call and Webcast on Tuesday, July 31

CHATSWORTH, Calif., July 19, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
July 17, 2012 17:30 ET | Source: IRIS International, Inc.

IRIS International Announces Distribution Agreement With Alifax and Launch of ESR Automated Instrumentation

CHATSWORTH, Calif., July 17, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
June 06, 2012 18:21 ET | Source: IRIS International, Inc.

IRIS International Announces Clinical Data Presentation of NADiA(R) ProsVue(TM) Benefits at the 5th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer

CHATSWORTH, Calif., June 6, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
May 25, 2012 10:41 ET | Source: IRIS International, Inc.

IRIS International to Present at Upcoming Investor Conferences

CHATSWORTH, Calif., May 25, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of...
May 21, 2012 08:30 ET | Source: IRIS International, Inc.

IRIS International Unveils NADiA(R) ProsVue(TM) at the American Urological Association (AUA) Annual Meeting, May 19-24, 2012

Test Identifies Patients at Reduced Risk for Prostate Cancer Clinical Recurrence After Surgery CHATSWORTH, Calif., May 21, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a...
May 02, 2012 16:05 ET | Source: IRIS International, Inc.

IRIS International Announces First Quarter 2012 Revenue and Financial Results

Record revenue of $29.9 million in Q1 2012; 11% growth over Q1 2011 Gross margin of 53% in Q1 2012 GAAP EPS of $0.05 in Q1 2012 Reaffirming 2012 guidance of revenues in a range from...
April 13, 2012 16:10 ET | Source: IRIS International, Inc.

IRIS to Release First Quarter Financial Results and Host Conference Call and Webcast on Wednesday, May 2, 2012

CHATSWORTH, Calif., April 13, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a developer of...